COVID-19 Infectious Diseases

COVID-19 and Testing Times

India enters a small group of nations which have tested over 1 million samples for COVID-19. Some reflections on the scale of the success and what it entails.

Disclaimer: This post represents my personal opinion. This does not represent the opinion or policy position of my employer or any organization or agency or group that I am affiliated with.

The global spread of the COVID-19 pandemic has brought us face to face with new realities and unanticipated challenges. Globally, health systems have needed to adapt and change strategies as the changing epidemiology and emerging data has provided us with more intelligence about this viral contagion. The basic strategy to combat COVID-19 is simple: prevent the occurrence of new cases; detect new cases early and effectively, as soon as they appear; treat the cases to prevent occurrence of complications and death; and manage them through social distancing strategies to prevent the spread. One of the key components of this strategy is testing to identify the new cases. Given the novel nature of the pathogen, and the limited capacity to produce quality assured testing kits, this was a major challenge globally. In a country of 1.3 billion people, strategic optimization of the limited testing resources is essential to ensure equitable access. There has been accelerated scaling up of testing capacity in India, with a 70-fold increase in daily tests done in the last 40 days. Along with this exponential increment in testing in India, there has been a gradual widening of the ambit of testing beyond the high-risk groups, consistently conducting around 25 tests for every positive case detected over the same period.

Testing Status: May 3, 2020

India has entered a select group of countries, which have conducted over 1 million tests for COVID-19. When compared to the other nine countries, India has the lowest number of cases (39,980 as of 3rd May, 2020) and lowest population-based mortality (0.9 per million) from COVID-19. These numbers in themselves are remarkable, but given the complexities of scaling up a real time PCR based diagnostic test over a vast terrain such as India, it stands as a testimony to the political will, foreplanning and broad-based support required to achieve this.

Total cases, deaths per million and total tests of COVID-19 in countries with 1 million or more total tests done

The testing strategy has kept pace with the changing transmission dynamics of COVID-19. In the early stages of the epidemic in India, when transmission was limited to travelers coming from countries where there was already ongoing transmission of COVID-19, testing was limited to high risk travelers and was augmented with screening at ports of entry, in tandem with travel and visa restrictions for select high burden countries. As the infection began to spread, testing was also ramped up. Iterative calibration of the testing strategy, keeping pace with the evolving epidemiology of COVID-19, has enabled access to diagnostic testing for groups that need it most, ensured the prevention of wasteful or unnecessary testing and encouraged optimal scaling up of the testing infrastructure while other preventive public health interventions were being put in place.

COVID-19 Burden in India (May 3, 2020)

Although testing is an important window into the evolution of COVID-19 in India, it is not a single-point panacea to help survive the pandemic. It is part of a larger package of interventions, and as such, needs to be recursively supportive of the other strategies. Multi-pronged approaches like physical distancing, bolstering health services infrastructure, and public health measures informed by optimal testing in sync with epidemic progression are necessary to beat COVID-19.

Skeptic Oslerphile. PhD Student in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. Past: 1) Public Health Scientist and Program Manager, Translational Global Health Policy Research Cell, Department of Health Research, Ministry of Health and Family Welfare, Government of India. 2) Scientist, Indian Council of Medical Research, National Institute of Cholera and Enteric Diseases; 3) Senior Research Associate, Public Health Foundation of India. Interests include: Emerging Infections, Public Health, Antimicrobial Resistance, One Health and Zoonoses, Diarrheal Diseases, Medical Education, Medical History, Open Access, Healthcare Social Media and Health2.0. Opinions are my own!

1 comment on “COVID-19 and Testing Times

  1. As of April 5, India had performed a little over 100,000 tests a rate of nearly 47 tests per million people compared with 4,572 tests per million in the U.S. 2,753 tests per million in the U.K, and 8,800 per million in South Korea. At present, India is not adequately testing to identify new cases, which might be masking the true number.


Debates and Discussions...

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: